Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FBIO | AMGN | BMY | VRTX | GILD |
| Company | Fortress Biotech Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.9700 | 276.97 | 56.00 | 422.73 | 92.01 |
| High | 1.9700 | 276.97 | 56.62 | 428.25 | 92.80 |
| Low | 1.8600 | 269.78 | 55.55 | 419.27 | 91.68 |
| Last | 1.8700 | 272.11 | 56.29 | 422.00 | 91.84 |
| Change | -0.0400 | +2.68 | -0.09 | +5.04 | +0.19 |
| % Change | -2.09% | +0.99% | -0.16% | +1.21% | +0.21% |
| Volume | 313,300 | 3,244,200 | 10,911,600 | 1,773,500 | 6,862,200 |
| 20-Day Average Volume | 657,950 | 3,507,620 | 10,784,580 | 2,097,760 | 6,621,070 |
| Previous Close | 1.9100 | 269.43 | 56.38 | 416.96 | 91.65 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9898 | 263.65 | 56.68 | 410.50 | 91.78 |
| 20-Day Raw Stochastic | 25.76% | 79.47% | 39.63% | 47.37% | 54.68% |
| 20-Day Relative Strength | 47.27% | 48.46% | 48.76% | 45.68% | 51.97% |
| Weighted Alpha | -32.24 | -14.36 | +17.59 | -7.30 | +15.35 |
| Today's Opinion | 56% Buy | 88% Sell | 40% Buy | 72% Sell | 56% Buy |
| Previous Opinion | 72% Buy | 88% Sell | 40% Buy | 72% Sell | 40% Buy |
| Last Month's Opinion | 8% Buy | 88% Sell | 80% Buy | 24% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.88% since 01/10/25 | +3.77% since 01/10/25 | +0.82% since 01/10/25 | +3.04% since 01/10/25 | +2.18% since 01/10/25 |
| Low | 1.8400 on 01/15/25 | 261.28 on 01/13/25 | 54.81 on 01/13/25 | 397.24 on 01/13/25 | 89.02 on 01/13/25 |
| High | 2.0200 on 01/13/25 | 276.97 on 01/17/25 | 56.74 on 01/15/25 | 428.25 on 01/17/25 | 93.07 on 01/16/25 |
| 1-Month | |||||
| %Chg | +2.75% since 12/17/24 | +2.32% since 12/17/24 | -2.36% since 12/17/24 | -10.07% since 12/17/24 | -1.03% since 12/17/24 |
| Low | 1.7000 on 12/23/24 | 253.30 on 12/19/24 | 54.81 on 01/13/25 | 377.85 on 12/19/24 | 88.57 on 01/10/25 |
| High | 2.3600 on 01/07/25 | 276.97 on 01/17/25 | 58.54 on 12/18/24 | 471.05 on 12/18/24 | 94.55 on 12/26/24 |
| 3-Month | |||||
| %Chg | +3.31% since 10/17/24 | -15.32% since 10/17/24 | +5.85% since 10/17/24 | -15.39% since 10/17/24 | +5.13% since 10/17/24 |
| Low | 1.4100 on 11/15/24 | 253.30 on 12/19/24 | 51.81 on 10/28/24 | 377.85 on 12/19/24 | 85.60 on 10/22/24 |
| High | 2.3600 on 01/07/25 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -7.43% since 07/17/24 | -18.94% since 07/17/24 | +30.45% since 07/17/24 | -13.59% since 07/17/24 | +25.29% since 07/17/24 |
| Low | 1.3550 on 09/24/24 | 253.30 on 12/19/24 | 41.60 on 07/19/24 | 377.85 on 12/19/24 | 70.78 on 07/23/24 |
| High | 2.8900 on 07/23/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 51,621 | 146,268,096 | 114,166,088 | 108,677,232 | 114,457,056 |
| Shares Outstanding, K | 27,605 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 84,510,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -60,640,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 14,630,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -12,870,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.67 | 0.56 | 0.45 | 0.40 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.76 on 11/14/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/12/24 | 02/04/25 | 02/06/25 | 02/03/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.620 on 01/03/25 | N/A | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.02 | 48.19 | 0.00 | 20.69 |